Welcome to the e-CCO Library!

P699: Machine Learning-based Prediction for Early Progression in Korean Crohn’s disease: Results from the IMPACT Study
Year: 2022
Source: ECCO'22
Authors: Chun, J.(1);Suji, K.(2);Kwang Sung, A.(3);Soo Kyung, P.(4);Sangsoo, K.(2);Dong Il, P.(4);
Created: Friday, 11 February 2022, 3:56 PM
P699: Radiologic response reduces the risk of small-bowel surgery in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Hallé1*, M. Azahaf1, N. Duveau2, M. Nachury1, J. Branche1, R. Gerard1, P. Wils1, P. Desreumaux1, O. Ernst1, B. Pariente1

Created: Thursday, 21 February 2019, 9:14 AM
P699: Ustekinumab therapy after biologic failure in patients with Crohn's Disease – A real-world single centre experience​​
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Majumder, S.(1,2,3)*;Bazarova, A.(4);Lorenzo Parigi, T.(1,3); Love , M.(5);Davis , J.(3);Ghosh, S.(6); Iacucci , M.(1,3,7);N. Shivaji, U.(1,3,7);
Created: Friday, 14 July 2023, 11:12 AM
P700 Effect of vitamin D in disease activity score and clinical relapse in patients with inflammatory bowel disease: A systematic review and meta-analysis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. Guzman1, O. Samson1, J.P. Segal2, J.K. Limdi3, B. Hayee4

Created: Thursday, 30 January 2020, 10:12 AM
P700: A high CRP before surgery and early medical prophylaxis predict postoperative endoscopic Crohn’s disease recurrence
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Sooben1, L. Thin1*, S. Picardo2, B. Mackinnon3, J. Ryan4, M.H. Wallace4,5

Created: Thursday, 21 February 2019, 9:14 AM
P700: Epidemiology of genital lymphoedema as the initial presentation of paediatric Crohn's disease
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Jagger F.*1, Dall A.2, Henderson P.2, Wilson D.1

Created: Wednesday, 20 February 2019, 10:36 AM
P700: Perceptions towards established and emerging dietary therapies for Crohn's disease management among the adult patients: results from a questionnaire survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Jatkowska, A.(1);White, B.(1);Jaskolski, P.(1);Brownson, E.(2);Clowe, J.(2);Seenan, J.P.(2);Gerasimidis, K.(1)*;MacDonald, J.(2);
Created: Friday, 14 July 2023, 11:12 AM
P700: The efficacy of colesevelam to treat bile acid malabsorption in Crohn's disease: data from TOPPIC trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Devarakonda*1, I. Arnott2, J. Satsangi3

Created: Friday, 22 February 2019, 9:41 AM
P700: The GEM Project: Stool metabolomic profile is associated with microbiome risk score and with future onset of Crohn’s disease in healthy first-degree relatives
Year: 2022
Source: ECCO'22
Authors: Lee , S.H.(1);Raygoza Garay , J.A.(1);Turpin , W.(1);Smith , M.I.(1);Goethel , A.(1);Griffiths , A.(2);Moayyedi , P.(3);Espin-Garcia , O.(4);Abreu , M.(5);Aumais , G.(6);Bernstein , C.N.(7);Biron , I.(8);Cino , M.(9);Deslandres , C.(10);Dotan , I.(8);El-Matary , W.(11);Feagan , B.(12);Guttman , D.(13);Huynh , H.(14);Hyams , J.(15);Jacobson , K.(16);Mack , D.(17);Marshall , J.(3);Otley , A.(18);Panaccione , R.(19);Ropeleski , M.(20);Silverberg , M.S.(1);Steinhart , A.H.(1);Turner , D.(21);Yerushalmi , B.(22);Xu , W.(4);Croitoru , K.(1);
Created: Friday, 11 February 2022, 3:56 PM
P701 New onset spondyloarthropathy in vedolizumab treated IBD patients
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.M. Tetley1, T. Lobaton2, M. Truyens2, K.H. Katsanos3, K.H.N. de Boer4, A. Pattinson5, T. Molnar6, R. Filip7, G. Michalopoulos8, S. Sebastian5

Created: Thursday, 30 January 2020, 10:12 AM
P701: A time-to-event model relating infliximab trough concentrations to the risk of relapse after extending the infusion interval
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kantasiripitak, W.(1);Outtier, A.(2,3);Thomas, D.(1);Sabino, J.(2,3);Vermeire, S.(2,3);Ferrante, M.(2,3);Dreesen, E.(1)*;
Created: Friday, 14 July 2023, 11:12 AM
P701: Compositional and functional alterations of the gut microbiome are associated with impaired intestinal permeability in healthy relatives of patients with Crohn's disease
Year: 2022
Source: ECCO'22
Authors: Leibovitzh, H.(1);Lee, S.H.(1);Xue, M.(1);Raygoza Garay, J.A.(1);Hernandez-Rocha, C.(1);Madsen, K.L.(2);Meddings, J.B.(3);Guttman, D.S.(4);Espin-Garcia, O.(5);Smith, M.I.(6);Goethel, A.(6);Moayyedi, P.(7);Steinhart, A.H.(1);Panancionne, R.(8);Huynh, H.(9);Jacobson, K.(10);Aumais, G.(11);Mack, D.R.(12);Abreu, M.(13);Bernstein, C.N.(14);Marshall, J.K.(15);Turner, D.(16);Xu, W.(5);Turpin, W.(1);Croitoru, K.(1);
Created: Friday, 11 February 2022, 3:56 PM
P701: Late-onset Crohn's disease is associated with high risk of intestinal perforation and low risk of perianal fistula as compared with early-onset Crohn's disease: the CONNECT cohort
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Kim H.M.*1, Kim H.-S.1, Kim J.S.2, Kim Y.S.3, Cheon J.H.4, Ye B.D.5, Kim Y.H.6, Han D.S.7

Created: Wednesday, 20 February 2019, 10:36 AM
P701: Quality of life of patients with inflammatory bowel diseases who live with an ostomy: Results of a French national survey
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Pineton de Chambrun1*, M. Liberatore2, A. Buisson2, P. Blanc1, A. Olympie2

Created: Thursday, 21 February 2019, 9:14 AM
P701: The comparative safety of different intravenous iron preparations in inflammatory bowel disease: a systematic review and network meta-analysis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Aksan*1,2, H. Işık2, K. Farrag1,3, A. Dignass4, J. Stein1,3

Created: Friday, 22 February 2019, 9:41 AM
P702 Treatment decisions in older inflammatory bowel disease patients: Applying gut feeling in an evidence-based era? A qualitative study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Waars1, V. Asscher1, A. Pieterse2, A. van der Meulen-de Jong1, S. Mooijaart3,4, J. Maljaars1

Created: Thursday, 30 January 2020, 10:12 AM
P702: Clinical and biomarker remission is maintained after switch from monthly dosed intravenous to subcutaneous maintenance treatment with vedolizumab in Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Spela, P.(1)*;Hanžel, J.(2);Smrekar, N.(2);Koželj, M.(2);Drobne, D.(2);Kurent, T.(2);Štabuc, B.(2);Novak, G.(2);
Created: Friday, 14 July 2023, 11:12 AM
P702: Faecal Microbiota Transplantation Sculpts the faecal and mucosal microbial and metabolomic profiles in patients with Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Bajaj, A.(1);Markandey, M.(1);Singh, M.(1);Virmani, S.(1);Vuyyuru, S.K.(1);Kante, B.(1);Thirunavukkarasu, R.(2);Verma, M.(1);Kumar, P.(1);Kshetrapal, P.(2);Makharia, G.(1);Gupta, D.(3);Kedia, S.(1);Ahuja, V.(1);
Created: Friday, 11 February 2022, 3:56 PM
P702: Head-to-head comparison of biological drugs in the treatment of ulcerative colitis: Suggestions from a real-life, inception cohort, single-centre study on consecutive post-marketing treatments
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Cassinotti1, N. Mezzina1*, A. Massari1, S. Grillo2, S. Ardizzone1

Created: Thursday, 21 February 2019, 9:14 AM